IRCT2017060212789N14已完成3 期
The effect of Rosvastatin on steatosis and fibrosis in patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial study
Vice Chancellor for Research of Kurdistan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 70 years（—）
- 性别
- All
入选标准
- •Main Inclusion Criteria: Non diabetics patients; normal FBS; BS2hpp;Hb1AC; Age 20 years and older; approved non fatty liver diagnosed by fibroscan; LFT(AST and ALT); rejection of other causes of fatty liver disease such as hepatitis B and C .
排除标准
- •Patients who have other liver diseases; contraindication for Rosvastatin; not taking hypoglycemic drugs such as metformin.
研究者
相似试验
已完成
4 期
Effect of drug rosuvastatin in females with type 2 diabetes mellitusCTRI/2018/07/014844Sri Venkateswara Institute of Medical Sciences29
已完成
不适用
Effect of Rosuvastatin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome : Assessment by frequencey domain optical coherence tomography studyAcute Coronary Syndrome patients who have thin-cap fibroatheroma in non-culprit lesionJPRN-UMIN000011719Yamaguchi University Graduate School of Medicine Department of Medicine and Clinical Science20
进行中（未招募）
1 期
Statin effect on atheroma calcificatioAtherosclerosis, namely in the aorta, carotid and coronary arteriesEUCTR2018-003837-13-PTCentro Hospitalar e Universitário de Coimbra, E.P.E.44
已完成
4 期
Effect of the drug Rosuvastatin in lowering the risk of heart disease in diabetes patientsCTRI/2017/09/009695Sri Venkateswara Institute of Medical Sciences40
进行中（未招募）
4 期
The effect of statin and fibrate therapy on vascular function in chronic kidney diseaseCardiovascualr disease in patients with chronic kidney diseaseCardiovascular - Other cardiovascular diseasesRenal and Urogenital - Kidney diseaseACTRN12605000240640Pfizer CVL Grants105